Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v8-FR
Language English French
Date Updated 2020-02-05 2020-02-04
Drug Identification Number 02248151 02248151
Brand name ALPHAGAN P ALPHAGAN P
Common or Proper name brimonidine tartrate brimonidine tartrate
Company Name ABBVIE CORPORATION ABBVIE CORPORATION
Ingredients BRIMONIDINE TARTRATE BRIMONIDINE TARTRATE
Strength(s) 0.15% 0.15%
Dosage form(s) SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 10ml 10ml
ATC code S01EA S01EA
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-12-06 2019-12-06
Estimated end date 2020-01-07 2020-01-07
Actual end date 2020-02-04 2020-02-04
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Alternate size of Alphagan P 5ml is available. Alternate size of Alphagan P 5ml is available.
Health Canada comments